Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb;34(2):310-317.
doi: 10.1007/s11695-023-06982-9. Epub 2023 Dec 18.

Banded Versus Non-banded Sleeve Gastrectomy: 5-Year Results of a 3-Year Randomized Controlled Trial

Affiliations

Banded Versus Non-banded Sleeve Gastrectomy: 5-Year Results of a 3-Year Randomized Controlled Trial

Jodok M Fink et al. Obes Surg. 2024 Feb.

Abstract

Purpose: Banded sleeve gastrectomy (BSG) has been shown to enable better weight loss than non-banded sleeve gastrectomy (SG) in retrospective analyses. These findings were supported by two randomized controlled trials (RCT). However, to date, mid-term prospective data is not available.

Materials and methods: We invited all 94 patients of an RCT comparing banded to non-banded sleeve gastrectomy at 3 years (DRKS00007729) for a 5-year follow-up visit. Eighty-two patients (BSG n = 42; SG n = 40) came for evaluation. Outcome measures were identical with the RCT to allow longitudinal comparison. Data analysis was descriptive and focused on biometric data, development of comorbidities, mid-term complications, quality of life, and type of body contouring surgery (BCS).

Results: The per-protocol analysis revealed a treatment difference of 9% (CI - 1.5 to 19.6) excess weight loss (EWL). Total weight loss (TWL) was 27.4% (CI 23.5-31.3) after SG and 31.6% (CI 27.3-35.5) after BSG. Twenty percent of patients after SG and 11.9% following BSG had been converted to a gastric bypass. Type 2 diabetes went into remission in most patients (SG 66.7% vs. BSG 63.6%). Antihypertensive medication was stopped or reduced in 81.3% after SG and 80% after BSG. Reflux symptoms were similar in both groups (symptoms [Formula: see text] 1/ week: SG 28.2% vs. BSG 26.8%). Frequency of postprandial regurgitation was higher after BSG (SG 23% vs. BSG 59%). Forty percent of patients had undergone BCS at time of follow-up.

Conclusion: Five-year weight loss after BSG was 9% EWL and 4.2% TWL higher compared to SG. The main added morbidity following BSG was postprandial regurgitation.

Keywords: Banded sleeve gastrectomy; Bariatric surgery; Sleeve gastrectomy; Weight loss.

PubMed Disclaimer

Conflict of interest statement

Jodok Fink, Gabriel Seifert, and Goran Marjanovic have received speaking honoraria from Medtronic GmbH, Meerbusch, and KLS Martin Group, Tuttlingen. All other authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart of all patients throughout the randomized controlled trial (RCT) and current follow-up. Results of the RCT (dotted line) were published previously [10]. The chart enumerates all bariatric revisions. In total, 8 revisions were conducted in 6 patients after BSG and 12 revisions in 8 patients following SG
Fig. 2
Fig. 2
Spaghetti plot depicting excess weight loss (%EWL; Fig. 2A) and total weight loss (%TWL; Fig. 2B) after sleeve gastrectomy (SG) and banded sleeve gastrectomy (BSG). Displayed data relate to the per-protocol population. Bold lines indicate mean modelled weight loss of the mixed effects analysis. The estimated %EWLdifference between SG vs. BSG was 9.0%, the %TWL delta 4.2%. Data to the left of the dotted line depict the RCT results and have been published previously [10]

Similar articles

Cited by

References

    1. Sharples AJ, Mahawar K. Systematic review and meta-analysis of randomised controlled trials comparing long-term outcomes of Roux-En-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2020;30(2):664–672. doi: 10.1007/s11695-019-04235-2. - DOI - PubMed
    1. Nielsen HJ, Nedrebo BG, Fossa A, et al. Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy. Int J Obes (Lond) 2022;46(4):739–749. doi: 10.1038/s41366-021-01028-5. - DOI - PMC - PubMed
    1. Howard R, Chao GF, Yang J, et al. Comparative safety of sleeve gastrectomy and gastric bypass up to 5 years after surgery in patients with severe obesity. JAMA Surg. 2021;156(12):1160–1169. doi: 10.1001/jamasurg.2021.4981. - DOI - PMC - PubMed
    1. Qumseya BJ, Qumsiyeh Y, Ponniah SA, et al. Barrett's esophagus after sleeve gastrectomy: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93(2):343–352 e2. doi: 10.1016/j.gie.2020.08.008. - DOI - PubMed
    1. Uhe I, Douissard J, Podetta M, et al. Roux-en-Y gastric bypass, sleeve gastrectomy, or one-anastomosis gastric bypass? A systematic review and meta-analysis of randomized-controlled trials. Obesity (Silver Spring) 2022;30(3):614–627. doi: 10.1002/oby.23338. - DOI - PMC - PubMed